ALEJANDRO PAZ: Open Payments
NPI 1760400386 · ESCONDIDO, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$794 in 25 payments from 11 companies in 2025. Trend: 2023 $271 · 2024 $425 · 2025 $794
Food & beverage: $794
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 3 | $290 |
| Novo Nordisk Inc | 5 | $111 |
| GlaxoSmithKline, LLC. | 4 | $90 |
| Gilead Sciences, Inc. | 2 | $82 |
| Boston Scientific Corporation | 1 | $55 |
| Lilly USA, LLC | 3 | $48 |
| Otsuka America Pharmaceutical, Inc. | 2 | $39 |
| PFIZER INC. | 2 | $32 |
| Merck Sharp & Dohme LLC | 1 | $19 |
| Amgen Inc. | 1 | $19 |
Products named: BREZTRI, SHINGRIX, Rybelsus, WaveWriter Alpha Prime 16, Trodelvy, Ozempic, AIRSUPRA, REXULTI.
Industry payments across CA — which companies pay providers there.
